Drugs / platelet rich fibrin matrix
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01590238 | May 2012 → Sep 2013 | alopecia | The New York Eye & Ear Infirmary | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | platelet rich fibrin matrix | “4-8 cc of autologous platelet rich fibrin matrix (PRFM) is isolated from 9-18 cc of peripheral blood.” NCT01590238 ↗ |
| Known as | PRFM | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01590238 ↗ |
| Route | Other | “PRFM is then injected intradermally in 0.10 cc aliquots” NCT01590238 ↗ |